Dashboard
Manage Tickers

MGNX MACROGENICS INC

Nasdaq macrogenics.com


$ 1.56 $ -0.10 (-6.02 %)    

Thursday, 13-Nov-2025 10:50:55 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 611.68 $ -5.97 (-0.97 %)
DIA $ 479.60 $ -1.74 (-0.36 %)
SPY $ 676.16 $ -4.33 (-0.64 %)
TLT $ 89.80 $ 0.00 (0 %)
GLD $ 386.11 $ -1.14 (-0.29 %)
$ 1.47
$ 1.68
$ 1.56 x 5,389
$ 1.57 x 902
$ 1.55 - $ 1.73
$ 0.99 - $ 4.16
785,401
na
92.99M
$ 1.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-20-2025 12-31-2024 10-K
5 11-05-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-07-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-15-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-03-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 07-29-2021 06-30-2021 10-Q
19 04-29-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-04-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-07-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-02-2017 06-30-2017 10-Q
35 05-03-2017 03-31-2017 10-Q
36 02-28-2017 12-31-2016 10-K
37 11-02-2016 09-30-2016 10-Q
38 08-03-2016 06-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
11/13/2025 12:06:08

macrogenics-q3-eps-027-beats-058-estimate-sales-72839m-beat-14700m-estimate
Macrogenics Q3 EPS $0.27 Beats $(0.58) Est...
11/12/2025 21:41:12

Macrogenics (NASDAQ:MGNX) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $(0.58) b...

hc-wainwright--co-reiterates-neutral-on-macrogenics-maintains-2-price-target
HC Wainwright & Co. Reiterates Neutral on ...
11/03/2025 12:02:43

HC Wainwright & Co. analyst Robert Burns reiterates Macrogenics (NASDAQ:MGNX) with a Neutral and maintains $2 price target.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/21/2025 21:06:06

macrogenics-q2-eps-057-beats-075-estimate-sales-22241m-beat-7700m-estimate
Macrogenics Q2 EPS $(0.57) Beats $(0.75) E...
08/14/2025 20:23:11

macrogenics-appoints-eric-risser-as-president-and-ceo-succeeds-scott-koenig
MacroGenics Appoints Eric Risser As Presid...
08/13/2025 20:03:01

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/10/2025 12:09:16

macrogenics-forged-a-zynyz-royalty-purchase-deal-with-sagard-healthcare-partners-for-70m-upfront-payment-extending-cash-runway-through-first-half-of-2027
MacroGenics Forged A ZYNYZ Royalty Purchas...
06/10/2025 11:11:33

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering, developing, manufacturing a...

4-analysts-assess-macrogenics-what-you-need-to-know
4 Analysts Assess Macrogenics: What You Ne...
05/20/2025 20:00:49

b-riley-securities-maintains-neutral-on-macrogenics-lowers-price-target-to-3
B. Riley Securities Maintains Neutral on M...
05/20/2025 14:52:57

B. Riley Securities analyst Mayank Mamtani maintains Macrogenics (NASDAQ:MGNX) with a Neutral and lowers the price target fr...

stifel-maintains-hold-on-macrogenics-lowers-price-target-to-5
Stifel Maintains Hold on Macrogenics, Lowe...
05/14/2025 15:45:18

Stifel analyst Stephen Willey maintains Macrogenics (NASDAQ:MGNX) with a Hold and lowers the price target from $6 to $5.

barclays-maintains-overweight-on-macrogenics-lowers-price-target-to-3
Barclays Maintains Overweight on Macrogeni...
05/14/2025 15:01:16

Barclays analyst Peter Lawson maintains Macrogenics (NASDAQ:MGNX) with a Overweight and lowers the price target from $8 to $3.

macrogenics-q1-eps-065-beats-076-estimate-sales-1319m-beat-617m-estimate
Macrogenics Q1 EPS $(0.65) Beats $(0.76) E...
05/13/2025 20:21:26

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.76) b...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

a-look-at-macrogenicss-upcoming-earnings-report
A Look at Macrogenics's Upcoming Earnings ...
05/12/2025 21:03:55

hc-wainwright--co-maintains-neutral-on-macrogenics-lowers-price-target-to-2
HC Wainwright & Co. Maintains Neutral on M...
03/25/2025 11:09:16

HC Wainwright & Co. analyst Robert Burns maintains Macrogenics (NASDAQ:MGNX) with a Neutral and lowers the price target ...

macrogenics-2024-eps-107-down-from-015-yoy
MacroGenics 2024 EPS $(1.07) Down From $(0...
03/20/2025 20:12:31

earnings-scheduled-for-march-20-2025
Earnings Scheduled For March 20, 2025
03/20/2025 08:32:14

peeling-back-the-layers-exploring-macrogenics-through-analyst-insights
Peeling Back The Layers: Exploring Macroge...
11/07/2024 15:00:48

jmp-securities-downgrades-macrogenics-to-market-perform
JMP Securities Downgrades Macrogenics to M...
11/07/2024 11:55:20

JMP Securities analyst Silvan Tuerkcan downgrades Macrogenics (NASDAQ:MGNX) from Market Outperform to Market Perform.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION